News & Events

ChemGenex Pharmaceuticals Limited (ASX: CXS) will host an investor teleconference on Thursday 6th May at 11am Australian Eastern Standard Time (Wednesday 5th May at 6.00pm US Pacific time) to provide an update on the regulatory status of the company’s lead product, OMAPRO, in the US and Europe.

 

As part of an ongoing investor awareness program Greg Collier, Ph.D., Chief Executive Officer and Managing Director, ChemGenex will be presenting an update at the RBS Morgans Life Science conference in Sydney today, Tuesday 4th May 2010.

 

Investor teleconference details

The teleconference will be held on Thursday 6th May 11am AEST / Wednesday 5th May 6pm PST.

 

International toll free access numbers:

Australia 1800 152 721

Australia (metered call) +61 2 8212 8333

USA/ Canada 1866 307 0659

France 0805100294

Germany 08000003882

Hong Kong 800933733

Indonesia 0018030113830

New Zealand 0800084460

Singapore 8006162259

Switzerland 0800000601

United Kingdom 08082389067

 

Participant Pin No: 480377#

 

Dial in details for any other locations or further information is available from Kyahn Williamson - kwilliamson@bcg.com.au / +61 40 101 8828.